Literature DB >> 17252020

JAK3 mutations occur in acute megakaryoblastic leukemia both in Down syndrome children and non-Down syndrome adults.

H Kiyoi, S Yamaji, S Kojima, T Naoe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17252020     DOI: 10.1038/sj.leu.2404527

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  29 in total

1.  Mutational analysis of SOS1 gene in acute myeloid leukemia.

Authors:  Ryohei Tanizaki; Akira Katsumi; Hitoshi Kiyoi; Shinji Kunishima; Toshihiro Iwasaki; Yuichi Ishikawa; Miki Kobayashi; Akihiro Abe; Tadashi Matsushita; Takashi Watanabe; Tetsuhito Kojima; Kozo Kaibuchi; Seiji Kojima; Tomoki Naoe
Journal:  Int J Hematol       Date:  2008-10-30       Impact factor: 2.490

Review 2.  Normal and malignant megakaryopoiesis.

Authors:  Qiang Wen; Benjamin Goldenson; John D Crispino
Journal:  Expert Rev Mol Med       Date:  2011-10-21       Impact factor: 5.600

3.  Hematopoietic disorders in Down syndrome.

Authors:  John K Choi
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

4.  Alternative TEL-JAK2 fusions associated with T-cell acute lymphoblastic leukemia and atypical chronic myelogenous leukemia dissected in zebrafish.

Authors:  Sara M N Onnebo; Parisa Rasighaemi; Janani Kumar; Clifford Liongue; Alister C Ward
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

5.  Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia.

Authors:  Hirotoshi Sakaguchi; Yusuke Okuno; Hideki Muramatsu; Kenichi Yoshida; Yuichi Shiraishi; Mariko Takahashi; Ayana Kon; Masashi Sanada; Kenichi Chiba; Hiroko Tanaka; Hideki Makishima; Xinan Wang; Yinyan Xu; Sayoko Doisaki; Asahito Hama; Koji Nakanishi; Yoshiyuki Takahashi; Nao Yoshida; Jaroslaw P Maciejewski; Satoru Miyano; Seishi Ogawa; Seiji Kojima
Journal:  Nat Genet       Date:  2013-07-07       Impact factor: 38.330

6.  Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models.

Authors:  Paola Rivera-Munoz; Anouchka P Laurent; Aurelie Siret; Cecile K Lopez; Cathy Ignacimouttou; Melanie G Cornejo; Olivia Bawa; Philippe Rameau; Olivier A Bernard; Philippe Dessen; Gary D Gilliland; Thomas Mercher; Sébastien Malinge
Journal:  Blood Adv       Date:  2018-07-10

Review 7.  Myeloid leukemia in Down syndrome.

Authors:  Irum Khan; Sébastien Malinge; John Crispino
Journal:  Crit Rev Oncog       Date:  2011

Review 8.  Malignancy in children with trisomy 21.

Authors:  Karen R Rabin; James A Whitlock
Journal:  Oncologist       Date:  2009-01-28

9.  NSC114792, a novel small molecule identified through structure-based computational database screening, selectively inhibits JAK3.

Authors:  Byung-Hak Kim; Jun-Goo Jee; Chang-Hong Yin; Claudio Sandoval; Somasundaram Jayabose; Daisuke Kitamura; Erika A Bach; Gyeong-Hun Baeg
Journal:  Mol Cancer       Date:  2010-02-11       Impact factor: 27.401

Review 10.  Donor cell leukemia after allogeneic peripheral blood stem cell transplantation: a case report and literature review.

Authors:  Makoto Murata; Yuichi Ishikawa; Haruhiko Ohashi; Seitaro Terakura; Kazutaka Ozeki; Hitoshi Kiyoi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2008-05-10       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.